Roche Fuzeon Dosing Convenience Is Challenge, Not Price – Physician Panel

The dosing convenience of Roche's injectable HIV drug Fuzeon could be one marketing challenge for the company, physician panelists predicted during a Banc of America-sponsored healthcare forum in New York City Dec. 11